Stereotaxis(STXS) - 2025 Q3 - Quarterly Results

Stereotaxis Reports 2025 Third Quarter Financial Results St. Louis, MO, November 11, 2025 (Globe Newswire) – Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today reported financial results for the third quarter ended September 30, 2025. "We continue to focus on driving commercial progress while advancing a robust portfolio of technologies through regulatory and development milestones," said David Fischel, Chairman and CEO. "This i ...